Genotyping in infants with thrombocytopenia could rule out FNAIT
A case report described a wrongful diagnosis of FNAIT that could have been prevented if HPA genotyping had been performed sooner.
News
-
-
Mothers report negative effects of FNAIT on emotional, physical health
According to a recent poster presentation, women with FNAIT reported negative effects on their emotional and physical health.
-
Study shows FNAIT-affected mothers need more support
In a recent study, mothers affected by FNAIT reported their diagnosis had a significant negative effect on their well-being.
-
FDA fast tracks J&J’s nipocalimab to reduce risk of FNAIT
Johnson & Johnson has announced the FDA’s fast track approval of nipocalimab for treating FNAIT in alloimmunized pregnant persons.
-
UNITY fetal antigen test to be used in phase 3 nipocalimab trial
BillionToOne will allow its UNITY fetal antigen test to be used to test patients in the phase 3 trial evaluating the safety and efficacy of nipocalimab.
- How I explain my baby’s FNAIT diagnosis to others
- How FNAIT influenced my family planning
- Why I chose to have a C-section due to FNAIT
From the
FNAIT Ambassador
FNAIT Ambassador
Learn more about FNAIT
Sign up for the latest news, perspectives, and information about FNAIT.
